StemRegen Forum 2026

Global Virtual Forum on Stem Cell Biology & Regenerative Medicine

Theme: Bridging Global Innovation in Cellular Reprogramming & Translational Therapies

September 16–18, 2026 | Zoom Meeting

00Days
00Hours
00Minutes
00Seconds
Submit Abstract Register Now

60+ Research Presenters • 40+ Countries

Scientific Overview

About the Forum

StemRegen Forum 2026 brings together cellular biologists, tissue engineers, clinicians, academic scholars, and biotech industry representatives specializing in stem cell biology and regenerative medicine. The online meeting serves as a technical platform to present current research data, discuss laboratory findings, and analyze engineering methods underlying modern cell therapies.

The program includes scheduled keynote presentations, speaker panels, and peer-reviewed sessions across five specific scientific tracks. The sessions focus on the mechanisms of cellular reprogramming, biomaterial design, CRISPR-based gene editing modifications, and regulatory compliance paths required for human clinical trials.

By maintaining a multi-disciplinary international registry of presenters, StemRegen Forum 2026 focuses on the exchange of structural methods, multi-laboratory project collaboration, and the step-by-step transition of basic cellular research into verified clinical trial models.

Forum Registry

30+ Global Speakers
5 Scientific Tracks
40+ Countries Represented
Digital Attendance Verification

Scientific Focus Tracks

Technical classifications for scheduled presentations

01

Cellular Reprogramming

iPSCs, direct reprogramming, epigenetic modification, pluripotency, and differentiation pathways.

02

Tissue Engineering

3D Bioprinting, organoid systems, biomaterials, structural scaffolds, and tissue vascularization.

03

Translational Therapies

Clinical trial dataset monitoring, cell-based immunotherapies, and automated tissue auto repair fields.

04

Gene Editing & CRISPR

In vivo cutting mechanics, safety profiles, off-target tracking arrays, and therapeutic gene delivery systems.

05

Regulatory & Logistics

FDA/EMA compliance criteria, scalable bio-manufacturing infrastructures, and bio-banking frameworks.

Submissions

Call for Abstracts

StemRegen Forum 2026 invites researchers, laboratory principal investigators, clinicians, and biotech developers to submit original laboratory data, translational observations, and completed case studies within stem cell research and regenerative pharmacology.

All submissions will undergo peer review. Due to limited presentation capacity, early submission is strongly recommended for tracking scheduling layout limits.

Presentation Formats

Keynote40 min + 5 min Q&A
Invited Speaker25 min + 5 min Q&A
Oral Presentation20 min + 5 min Q&A
E-PosterDigital format, gallery entry
Submit Abstract Data

Deadlines & Timestamps

June 30, 2026
Early Submission Cut-off
July 30, 2026
Standard Review Window
August 15, 2026
Final System Gateway Closing
Sept 16–18, 2026
Live Presentation Stream Schedule

Registration Tiers

Virtual stream bandwidth allocations based on document categorization

Category Type
Access Inclusions
Early Tier
Standard
Final
Speaker (Oral)
Accepted abstract data presentation slots and verification logs.
$129
$179
$229
Delegate / Attendee
Live streaming feed tracking, interactive panel rooms, and chat boards.
$149
$199
$249
E-Poster Author
Interactive digital gallery archiving and moderation entry points.
$99
$149
$199
Student / Scholar
University documentation registry required upon verification checks.
$89
$139
$189
Open Registration Gateway

Scientific Agenda Structure

Central schedule layout blocks for individual session channels

08:00
Virtual Stream Connections Open
09:00
Inauguration Assembly & Preliminary System Configuration Reviews
09:30
Keynote Sessions Block A: Future of Global Regenerative Core Protocols
13:00
Midday Session Maintenance Intermission
13:40
Parallel Functional Group Routing: Focus Tracks 01 & 02 Technical Feeds
09:00
Keynote Sessions Block B: Biomaterial Matrix Engineering & 3D Organoid Architecture
11:05
Laboratory Panels: CRISPR Off-Target Verification Schemes & Vector Logs
13:00
Midday System Break Window
13:40
Parallel Functional Group Routing: Focus Tracks 03 & 04 Technical Feeds
09:00
Keynote Sessions Block C: Scaled Bio-manufacturing Infrastructure Compliance Criteria
11:05
Emerging Investigator Reports: Clinical Pipeline Assessments & Trial Metrics
13:00
Midday System Break Window
16:00
Interactive E-Poster Gallery Moderation Matrix Channels
17:00
Closing Summary & Assembly Adjournment Protocols

Who Should Attend

  • Cellular Biologists & Principal Investigators
  • Tissue Engineers & Material Scientists
  • Pharma & Cell Therapy Technologists
  • Academic Research Fellows
  • Graduate Students & Postdocs

Why Attend

  • Compare laboratory data with international groups
  • Present original research abstracts for panel review
  • Identify technical milestones in drug translation steps
  • Establish contact for cross-institutional studies
  • List project findings within the specialized field directory
Scroll to Top